The high-performance liquid chromatographic fingerprints study of Awei capsules
Rong Han1★, Jie Xue1, Erwei Hua1, Longlong Zhou1★ Corresponding author
- 1The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
CORRESPONDENCE
Rong Han
The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Received: 09-02-2012; Revised: 13-02-2012.
Volume 9, Issue 33 · pp. 67–71 · PUBLISHED 5 March 2013 · DOI: 10.4103/0973-1296.108143
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Awei Capusules are Hospital preparation for Hyperlipidemia. It was composed by Awei, Magnoliae Officinalis and Polygonum Bistoral etc. Manufacture and quality standard of Awei Capusules had been studied. Results of animal pharmacodynamic and clinical study all displayed that Awei Capusules can reduce serum levels of TC, TG, LDL-C, increases HDL-C/TC. It was safe. It could improve hemorrheology and vessel function of blood stasis animal. On the basis of these, we studied on fingerprint of Awei capsule. Materials and Methods: The gradient elution method was used for analyzing samples on HPLC. Fingerprint similarity calculation software was used for data analysis. Results: We got a good separation of Awei Capusules peaks. There were 15 peaks in fingerprint of Awei capusles. Gallic acid, magnolol and honokiol were identified. Conclusion: HPLC fingerprinting of Awei Capusules can provide to reference. It can control preparations quality of Awei Capusules.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Han, R., Xue, J., Hua, E., & Zhou, L. (2013). The high-performance liquid chromatographic fingerprints study of Awei capsules. Pharmacognosy Magazine, 9(33), 67–71. https://doi.org/10.4103/0973-1296.108143